Viewing Study NCT06538064



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06538064
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-31

Brief Title: A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy CIDP in Routine Clinical Care
Sponsor: None
Organization: None

Study Overview

Official Title: A Global Real-World Study to Assess HyQvia Use and Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy CIDP Switching to HyQvia
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HYbISCUE
Brief Summary: The main aims of this study are to understand why adults with Chronic Inflammatory Demyelinating Polyradiculoneuropathy CIDP chose a certain treatment why they changed to HyQvia from another therapy how satisfied they are with HyQvia and their previous treatment how their work productivity and activity is impacted and learn about their CIDP signs and symptoms Other aims are to collect information on any medical problems or side effects during the treatment with HyQvia learn how effective treatment of CIDP with HyQvia is and understand details on the use of HyQvia in standard clinical routine as well on the need for healthcare intervention such as emergency room visits or hospital visits or stays

During the study data will be collected from medical records already available interviews with participants at study start and study completion and via questionnaires completed by participants

Participants will be treated as per the doctors or the clinics routine
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None